Provectus Biopharmaceuticals, Inc.
PVCT
$0.05
$0.00-0.75%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 199.79% | -42.65% | -18.25% | -60.00% | 1,203.72% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.52% | 3.30% | -2.21% | -23.05% | -29.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.88% | -33.93% | -82.63% | -78.72% | -93.76% |
| Total Current Assets | 140.88% | -29.11% | -41.86% | -63.42% | -28.98% |
|
|
|||||
| Total Current Assets | 140.88% | -29.11% | -41.86% | -63.42% | -28.98% |
| Net Property, Plant & Equipment | -32.12% | 597.62% | 339.32% | 237.86% | 174.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 103.97% | -13.31% | -30.69% | -47.64% | -15.65% |
|
|
|||||
| Total Accounts Payable | -28.91% | 9.58% | -35.28% | -14.71% | -0.82% |
| Total Accrued Expenses | 19.89% | 58.12% | 40.76% | 75.29% | -21.70% |
| Short-term Debt | 70.17% | 29.45% | 5.47% | -4.16% | -50.59% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 42.60% | 3.52% | -10.75% | -17.41% | -19.80% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 18.69% | 26.27% | -1.12% | 3.97% | -22.42% |
|
|
|||||
| Total Current Liabilities | 18.69% | 26.27% | -1.12% | 3.97% | -22.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 70.17% | 29.45% | 5.47% | -4.16% | -50.59% |
| Capital Leases | -48.12% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 17.64% | 27.43% | 0.35% | 5.82% | -21.18% |
|
|
|||||
| Common Stock & APIC | 1.71% | 1.56% | 2.02% | 2.36% | 3.23% |
| Retained Earnings | -1.82% | -2.16% | -2.11% | -2.60% | -2.49% |
| Treasury Stock & Other | 0.99% | 1.32% | 0.82% | -0.17% | 0.17% |
| Total Common Equity | -6.89% | -31.71% | -5.70% | -13.41% | 21.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 6.80% | 6.25% | 7.09% | 6.43% | 13.08% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 6.80% | 6.25% | 7.09% | 6.43% | 13.08% |
|
|
|||||
| Total Common Equity | -6.89% | -31.71% | -5.70% | -13.41% | 21.80% |
| Total Preferred Equity | 6.80% | 6.25% | 7.09% | 6.43% | 13.08% |
| Total Minority Interest | -226.32% | -118.34% | 59.60% | -- | -- |
| Total Equity | -7.03% | -32.78% | -5.59% | -13.73% | 21.81% |
|
|
|||||